(19)
(11) EP 0 533 837 A1

(12)

(43) Date of publication:
31.03.1993 Bulletin 1993/13

(21) Application number: 91912750.0

(22) Date of filing: 07.06.1991
(51) International Patent Classification (IPC): 
A61K 31/ 435( . )
A61K 31/ 445( . )
A61P 43/ 00( . )
C07D 487/ 04( . )
C07D 513/ 04( . )
A61K 31/ 44( . )
A61K 31/ 505( . )
C07D 471/ 04( . )
C07D 498/ 04( . )
(86) International application number:
PCT/US1991/004022
(87) International publication number:
WO 1991/019497 (26.12.1991 Gazette 1991/29)
(84) Designated Contracting States:
AT BE CH DE DK ES FR GB GR IT LI LU NL SE

(30) Priority: 12.06.1990 US 19900537195

(71) Applicant: SMITHKLINE BEECHAM CORPORATION
King of Prussia, PA 19406 (US)

(72) Inventors:
  • ADAMS, Jerry, Leroy
    Wayne, PA 19087 (US)
  • BENDER, Paul, Elliot
    Cherry Hill, NJ 08003 (US)
  • GALLAGHER, Timothy, Francis
    Harleysville, PA 19438 (US)
  • HEYS, John, Richard
    Malvern, PA 19355 (US)
  • PERCHONOCK, Carl
    Philadelphia, PA 19119 (US)
  • VILLANI, Anthony, John
    Lansdale, PA 19446 (US)

(74) Representative: Thompson, Clive Beresford 
SmithKline Beecham plc Corporate Intellectual Property SB House Great West Road
Brentford, Middlesex TW8 9BD
Brentford, Middlesex TW8 9BD (GB)

   


(54) INHIBITION OF 5-LIPOXYGENASE AND CYCLOOXYGENASE PATHWAY MEDIATED DISEASES